Investor Presentaiton

Impressive Track Record of Growth (All Figures in INR Billion) 272.8 Net Sales 39.3 CAGR 11.9 4.4 32% FYOO FY05 FY10 FY15 53.2 Operating Cash Flow 7.8 3.7 0.7 CAGR 34% FYOO FY05 FY10 FY15 78.2 EBITDA 13.6 4.2 1.1 CAGR 33% 4.0 0.8 FYOO FY05 FY10 FY15 29.5 13.1 47.8 FYOO FY05 FY10 FY15 19.9 SUN PHARMA Adjusted Net Profit CAGR 31% Free Cash Flow Adjusted 5.6 EPS (Rs) 5.0 CAGR CAGR 1.7 2.1 37% 0.4 31% 0.4 FYOO FY05 FY10 FY15 © Sun Pharmaceutical Industries Limited. All Rights Reserved. FYOO FY05 FY10 FY15 FY15 numbers include the impact of Ranbaxy merger 10

View entire presentation